An experimental Parkinson’s drug missed its primary goal in a mid-stage trial, Roche said, in what is the second setback this week for candidate treatments for the neurodegenerative condition.
Related Posts
Volkswagen Chooses Rivian’s Kjell Gruner to Lead U.S. Business
The German car maker said Gruner would take over as chief executive of Volkswagen’s America operations on Dec. 12.
Nike Paid Him to Make Gold-Dipped Sneakers for LeBron. Now, It Is Suing Him.
Sneaker giant is cracking down on customizers and designers like the Shoe Surgeon as it wages wider legal fights to defend its trademarks.
Tesla Sues EV-Battery Supplier Over Alleged Disclosure of Trade Secrets
According to the lawsuit, Matthews International allegedly improperly filed patent applications incorporating Tesla’s trade secrets without the electric-car maker’s consent.